Skip to Main ContentSkip to Footer

Testicular cancer

Overview

Testicular cancer is most common in men 15-35 years old. Treatment can affect your reproductive decisions in the future. Our specialized team compassionately guides you through your diagnosis, treatment options and follow-up care. We combine advanced research, technology and techniques with compassionate care to create a personalized care plan that meets your unique needs.

Meet Your Care Team

Scott M. Haake

Scott M. HaakeMD

    Hematology/Oncology, Urologic/Genitourinary Cancer
Kimryn Rathmell

Kimryn RathmellMD, PhD

    Hematology/Oncology, Medical Oncology, Urologic/Genitourinary Cancer
Austin N. Kirschner
star empty iconstar empty iconstar empty iconstar empty iconstar empty iconstar iconstar iconstar iconstar iconstar icon
4.9

Austin N. KirschnerMD, PhD

    Radiation Oncology
Eric T. Shinohara
star empty iconstar empty iconstar empty iconstar empty iconstar empty iconstar iconstar iconstar iconstar iconstar icon
4.9

Eric T. ShinoharaMD, MSCI

    Radiation Oncology
Daniel A. Barocas
star empty iconstar empty iconstar empty iconstar empty iconstar empty iconstar iconstar iconstar iconstar iconstar icon
4.8

Daniel A. BarocasMD, MPH, FACS

    Urologic/Genitourinary Cancer, Urology
Sam S. Chang
star empty iconstar empty iconstar empty iconstar empty iconstar empty iconstar iconstar iconstar iconstar iconstar icon
4.8

Sam S. ChangMD, MBA

    Urologic/Genitourinary Cancer, Urology
Duke Herrell III
star empty iconstar empty iconstar empty iconstar empty iconstar empty iconstar iconstar iconstar iconstar iconstar icon
4.8

Duke Herrell IIIMD, FACS

    Urologic/Genitourinary Cancer, Urology
David F. Penson
star empty iconstar empty iconstar empty iconstar empty iconstar empty iconstar iconstar iconstar iconstar iconstar icon
4.8

David F. PensonMD, MPH, MMHC

    Urologic/Genitourinary Cancer, Urology
Joseph A. Smith
star empty iconstar empty iconstar empty iconstar empty iconstar empty iconstar iconstar iconstar iconstar iconstar icon
4.9

Joseph A. SmithMD

    Urologic/Genitourinary Cancer, Urology

Why Choose Testicular Cancer Care at Vanderbilt

  • diploma, award, ribbon, Recognized care, quality
    Recognized cancer care

    The National Cancer Institute designates us as a Comprehensive Cancer Center, the highest ranking by the world’s leading authority on cancer.

  • medical chart, clipboard, cross, Knowledge and experience
    Knowledge and experience

    Our surgeons have performed more than 100 retroperitoneal lymph node dissection surgeries. Our depth of experience performing a high volume of this specialized procedure translates into expert, comprehensive care for you.

  • people, Tumor board, team, staff, partners
    Specialized tumor boards

    At our regular cancer care meetings, experts in your specific type of cancer from across medical disciplines work together to create a treatment plan for the most complex cases. This means expert, comprehensive care just for you.

  • lightning bolt, Innovation, advanced
    Innovation

    Our researchers are dedicated to developing new and more effective approaches to care. We not only apply the latest research, but also pioneer some of the latest innovations. You may have access to treatments before they are widely available.

  • medical record, Second opinions, cross, pen
    Second opinions

    Men diagnosed or treated elsewhere often seek a second opinion from our specialists. In fact, as members of the National Comprehensive Cancer Network, our experts help develop the guidelines that cancer doctors across the country follow.

  • marker, map, geo-fence, One convenient location
    One convenient location

    Our specialists offer all medical and support services in one place. With comprehensive care from imaging to treatment to recovery support in one location, you can focus on improving your health.

Tests, Treatments and Services

We offer a full range of tests, treatments and services, including:

Location

Related Information

For Referring Physicians

To refer a patient to Vanderbilt’s Testicular Cancers team, call (615) 343-3700.